Prescription drug coverage can change from one Medicare plan year to the next. A medication that was covered in 2026 may still be covered in 2027 but appear on a different tier, carry different cost-sharing, or come with updated coverage requirements. Pharmacy arrangements can change as well, which means beneficiaries should not assume that last year’s prescription experience will automatically carry forward.
For Florida Medicare beneficiaries, reviewing Part D formulary changes in Florida is therefore an important part of preparing for the 2027 plan year. Medicare Open Enrollment runs from October 15 through December 7, 2026, and changes made during this period generally take effect January 1, 2027. Medicare’s own 2026 handbook also identifies October 1 as the point when beneficiaries can begin comparing their current health or drug coverage with 2027 options.
A formulary review does not automatically mean changing plans. The more useful goal is to determine whether the prescription coverage someone already has will continue to fit the medications, pharmacy preferences, and other healthcare priorities that matter in the coming year.
ProCare Consulting is not affiliated with or endorsed by the U.S. government or the federal Medicare program. This disclaimer is required under ProCare’s Medicare marketing standards.
Why Do Medicare Part D Formulary Changes Matter for 2027?
A Medicare drug plan’s formulary is not something beneficiaries should review only when they first enroll. Plans can update their covered-drug lists, tier structures, cost-sharing, and coverage requirements, which means the way a prescription is covered can look different from one plan year to the next.
For someone who takes several medications regularly, even one meaningful change may deserve attention. The important question is not simply whether the plan itself still exists for 2027. It is whether the medications a beneficiary actually takes will continue to be covered in a way that fits their needs.
A Medication Can Still Be Covered but Work Differently Under the Plan
A medication does not have to disappear from a formulary for the member’s experience to change. It may remain covered but move to another tier, receive different copay or coinsurance treatment, or become subject to a coverage rule that did not previously apply.
Medicare notes that plans can organize formulary tiers differently. A lower tier will generally have lower cost-sharing than a higher tier, but each plan determines how its tiers are structured.
This is why simply seeing the drug’s name on a list is not always enough. Beneficiaries should also look at how the plan will cover that medication in 2027.
Review Changes Before January Refills
Waiting until a prescription is due for refill in January can make a plan change harder to understand in the moment. Reviewing the 2027 formulary during the fall provides time to identify questions about coverage, pharmacy participation, or plan requirements before the new plan year begins.
That review may ultimately confirm that the current coverage still fits. If a significant change does appear, the beneficiary then has more context for deciding whether another available option deserves consideration during an applicable enrollment period.
What Is a Medicare Part D Formulary?
A Medicare Part D formulary is a plan’s list of covered prescription drugs. Drug plans may organize those medications into tiers, and tier placement can influence the copayment or coinsurance associated with a prescription.
Formularies are plan-specific. Two drug plans may cover the same medication but place it on different tiers or apply different coverage rules. That makes it important to review the information for the specific plan being considered rather than relying on general assumptions about how Medicare Part D works.
What Are Drug Tiers?
Many Medicare drug plans place medications into different tiers. Medicare explains that plans may use different tier structures, although common examples include tiers for generic drugs, preferred brand-name drugs, non-preferred drugs, and higher-cost specialty medications.
Tier placement matters because it can affect cost-sharing. A medication that remains on the formulary but moves from one tier to another may be covered differently in the new plan year.
The tier number itself should not be evaluated in isolation. What matters is the actual cost-sharing and coverage requirements attached to the medication under the specific 2027 plan.
What Is the Difference Between a Copay and Coinsurance?
A copay is generally a set dollar amount that the member pays for a covered prescription under the plan’s terms.
Coinsurance, by contrast, is calculated as a percentage of the applicable drug cost.
Part D plans may use either structure depending on the plan and medication. There is no need to assume that one structure is automatically better. The relevant question is what the member would actually be responsible for under the specific plan and drug tier.
What Should You Check on Your 2027 Drug List?
A useful formulary review begins with the beneficiary’s own medication list. Instead of comparing plans based on broad marketing language or headline premiums, start with the prescriptions that are actually being filled.
Write down each medication, dosage, frequency, and preferred pharmacy. That creates a practical checklist for reviewing the 2027 formulary and plan details.
Is Each Medication Still Covered?
Start by confirming whether every current prescription appears on the plan’s updated drug list.
If a medication’s coverage appears different from the previous year, verify the change using current plan information. Medicare states that plans must provide notice of drug-list changes that affect medications a member is taking, but beneficiaries should still review their own plan materials rather than assuming that nothing has changed.
The goal at this stage is simply to identify changes accurately. A medication being handled differently does not, by itself, establish that the entire plan is no longer appropriate.
Has the Drug Moved to a Different Tier?
Next, look at the medication’s tier placement.
A change in tier can affect the cost-sharing attached to the prescription. Because each plan may structure tiers differently, beneficiaries should compare the actual 2027 plan information rather than relying only on the tier number.
This is especially important when several medications are involved. One change may look significant on its own but needs to be viewed alongside the coverage of the beneficiary’s complete prescription list.
Have Copays or Coinsurance Changed?
After confirming coverage and tier placement, review the applicable copay or coinsurance.
The focus should remain on the specific medications being used. ProCare’s compliance standards prohibit unsubstantiated savings claims, so a responsible comparison should not promise that changing plans will automatically reduce prescription spending.
Instead, compare the documented 2027 plan terms and determine how those terms apply to the prescriptions that matter to the beneficiary.
What Coverage Rules Should You Look For?
A formulary review involves more than checking whether a medication appears on a drug list. Medicare drug plans may use several types of utilization-management rules that affect how coverage works.
Medicare identifies prior authorization, step therapy, and quantity limits among the rules that plans may apply to certain drugs.
Prior Authorization
Prior authorization means the plan may require approval before it will cover a particular medication under its rules.
According to Medicare, the prescriber may need to provide information showing that the drug is medically necessary and that the beneficiary meets the plan’s requirements.
If a medication will require prior authorization in 2027, identifying that requirement ahead of time allows the beneficiary to understand what steps may be necessary rather than discovering the rule during a refill.
Step Therapy
Step therapy generally requires the beneficiary to try another covered medication before the plan will cover a different drug in certain circumstances.
Medicare notes that beneficiaries or their prescribers may be able to request an exception to a step-therapy requirement when the applicable criteria are met.
A formulary review should identify whether step therapy applies, but it should not become medical advice. Decisions about whether a different medication is clinically appropriate should remain between the beneficiary and the healthcare provider.
Quantity Limits
A quantity limit restricts how much of a drug the plan will cover within a particular period. Medicare gives the example of a plan covering a specified number of tablets in a month.
Someone taking a medication on an ongoing basis should verify whether a quantity limit applies and whether that rule has changed for 2027.
Again, the goal is not to assume that a coverage restriction makes a plan unsuitable. It is to understand the rule accurately and determine whether it affects the beneficiary’s actual prescription needs.
Why Does Your Pharmacy Matter?
The drug itself is only one part of a Part D comparison. The pharmacy used to fill prescriptions can also affect how the plan works.
Plans may have pharmacy networks and may distinguish between participating pharmacies in ways that influence cost-sharing. A pharmacy that worked well under the current plan year should therefore be checked again when reviewing 2027 coverage.
Check Whether Your Pharmacy Still Participates
If someone regularly uses the same local or mail-order pharmacy, verify its status under the 2027 plan.
Avoid assuming that participation remains unchanged simply because the pharmacy was part of the plan during 2026. Current plan information should be used for the comparison.
For beneficiaries who use several pharmacies, it may also be useful to identify which locations will remain convenient and how the plan treats prescriptions filled at those locations.
Review Preferred-Pharmacy Information
Some drug plans may offer different cost-sharing depending on the pharmacy being used.
That does not mean a preferred pharmacy will always be the right choice for every beneficiary, but it is another plan detail worth understanding when regular prescriptions are involved.
Rather than evaluating medication coverage and pharmacy information separately, review them together. A drug’s formulary placement may look appropriate, but pharmacy arrangements can still affect the way the coverage functions in practice.
What Does the 2027 Part D Out-of-Pocket Threshold Mean?
The Medicare Part D benefit includes an annual out-of-pocket threshold that limits cost-sharing for covered Part D drugs once the applicable amount is reached.
For 2027, CMS has finalized the Part D out-of-pocket threshold at $2,400, up from $2,100 in 2026. CMS describes the $2,400 figure as the 2027 threshold at which a beneficiary moves from the initial coverage phase into the catastrophic phase.
This is not an entirely new protection for 2027. The redesigned Part D benefit began using a reduced annual out-of-pocket threshold in earlier years, and CMS has finalized updated parameters for the 2027 plan year.
What Happens After the Threshold Is Reached?
Once the applicable Part D out-of-pocket threshold is reached, the beneficiary enters the catastrophic coverage phase and has no additional cost-sharing for covered Part D drugs for the remainder of the calendar year.
Medicare uses the term true out-of-pocket, or TrOOP, spending when calculating progress toward the threshold. This can include eligible payments made by the beneficiary and certain payments made on the beneficiary’s behalf.
The key point for beneficiaries is that the $2,400 threshold applies specifically within the Part D benefit. It should not be interpreted as eliminating every possible prescription or healthcare expense.
Why the Threshold Does Not Replace a Formulary Review
An annual spending threshold is an important protection, but it does not answer the basic questions a formulary review needs to address.
Beneficiaries still need to determine whether their medications are covered, which tiers they occupy, whether prior authorization or other rules apply, and how the plan’s pharmacy arrangements work.
For many people, those details will affect prescription coverage long before the annual threshold becomes relevant.
What Can You Do If a Medication Changes Coverage?
Discovering that a prescription will be handled differently in 2027 does not automatically tell a beneficiary what to do next. The first step should be verifying the change and understanding exactly how the plan will treat the medication.
From there, the appropriate next step depends on the type of change and the beneficiary’s circumstances.
Verify the Change With the Plan
If the formulary or plan documents show a change that could affect an important prescription, confirm the details with the plan.
Useful questions may include whether the drug is still covered, whether its tier has changed, whether prior authorization or step therapy applies, and whether pharmacy requirements have changed.
Obtaining clear plan-specific information is more reliable than making a coverage decision based on assumptions.
Ask About Coverage Rules or Available Options
When a drug is subject to a new restriction, beneficiaries may need to understand whether the plan provides an exception or coverage-determination process.
Medicare explains, for example, that members or prescribers may be able to request exceptions to certain step-therapy or quantity-limit requirements when the applicable conditions are met.
A beneficiary may also discuss clinically appropriate medication alternatives with the prescribing healthcare professional. An insurance advisor should not make that medical decision.
If the overall drug coverage no longer appears to fit, then comparing other available Medicare drug coverage during an applicable enrollment period may also be appropriate.
Do Not Switch Plans Based on One Number Alone
A single tier change, premium, or copay rarely tells the full story.
Before making a plan decision, look at the beneficiary’s complete medication list, pharmacy preferences, cost-sharing, coverage rules, and other relevant aspects of Medicare coverage.
That approach also aligns with ProCare’s compliance standards, which specifically prohibit moving Medicare clients between plans without documented client benefit.
How Should You Compare Part D Coverage for 2027?
The strongest Part D comparison starts with real prescription information rather than a generic list of benefits.
A beneficiary who comes to the review with a current medication list and preferred pharmacies can evaluate coverage around what will actually matter during the coming year.
Start With a Current Medication List
Before comparing drug coverage, gather:
medication names and dosages;
how often each medication is taken;
preferred local or mail-order pharmacies;
current plan information;
the 2027 formulary and plan materials when available.
This creates a consistent basis for comparing coverage rather than trying to remember prescription details while reviewing multiple plan documents.
Compare the Whole Prescription Picture
For each medication, look at several factors together:
formulary status;
tier placement;
copay or coinsurance;
prior authorization;
step therapy;
quantity limits;
pharmacy arrangements.
A plan that looks appealing in one area may work differently when the entire prescription list is considered. The purpose of comparison is therefore not to find the longest list of benefits or the lowest single number. It is to understand how the coverage fits the beneficiary’s actual prescriptions.
Keeping the Current Plan May Still Make Sense
An annual review does not need to end with a plan change.
If the medications remain appropriately covered, the relevant pharmacies continue to work for the beneficiary, and the overall plan still fits the person’s needs, staying with existing coverage may be a reasonable outcome.
That reflects ProCare Consulting’s core principle that insurance decisions should be based on fit rather than assuming one plan or carrier is universally better.
How Can a Licensed Medicare Advisor Help With a Formulary Review?
Medicare drug coverage can become difficult to compare because several details may affect the same prescription. A medication may be on the formulary but have a different tier, cost-sharing structure, pharmacy arrangement, or utilization rule.
A licensed Medicare advisor can help organize that information and explain it in plain language. This fits ProCare’s stated brand approach of simplifying insurance rather than relying on unexplained jargon or sales pressure.
Translate Plan Information Into Plain Language
A useful review should help the beneficiary understand what the formulary actually means for the medications being taken.
That may involve explaining tier placement, copays and coinsurance, prior authorization, step therapy, quantity limits, and pharmacy information. Where something requires verification, the advisor should identify that rather than making an unsupported assumption about coverage.
Compare Available Coverage Around the Client’s Medications
If another plan deserves consideration, the comparison should begin with the client’s actual prescriptions and healthcare priorities.
The objective is not to promise lower costs, guaranteed prescription coverage, or a particular outcome. ProCare’s compliance guidance requires marketing claims to be accurate, specific, and substantiated.
A responsible comparison instead shows how available options differ and gives the beneficiary clearer information for making a decision.
Keep the Decision Focused on Fit
ProCare Consulting’s Ground Truth includes a straightforward principle: “We work FOR clients, not insurance companies.”
Applied to a Part D formulary review, that means beginning with the client’s medications and circumstances rather than trying to fit the beneficiary into a predetermined plan recommendation.
The outcome may be a different plan, or the review may confirm that the current coverage still works. The value is in making that decision with a clearer understanding of the coverage.
Frequently Asked Questions
When should I review my 2027 Part D formulary?
Beneficiaries can begin reviewing available 2027 Medicare health and drug coverage information in the fall. Medicare Open Enrollment runs from October 15 through December 7, 2026, with applicable coverage changes generally taking effect January 1, 2027.
Does being on the formulary mean my medication will cost the same in 2027?
Not necessarily. A medication may remain covered while its tier, copay, coinsurance, pharmacy arrangements, or other plan requirements change. Review the specific 2027 plan information for each medication.
What should I check for each prescription?
Confirm whether the medication is covered, review its tier and applicable copay or coinsurance, and check for rules such as prior authorization, step therapy, or quantity limits. Pharmacy information should also be reviewed when it affects how the prescription is covered.
What is the 2027 Part D out-of-pocket threshold?
CMS has finalized the 2027 Part D out-of-pocket threshold at $2,400. Once the applicable threshold is reached, there is no additional beneficiary cost-sharing for covered Part D drugs during the catastrophic phase for the remainder of that calendar year.
Should I change plans if one medication moves tiers?
Not automatically. A tier change should be evaluated alongside the beneficiary’s other medications, pharmacy needs, plan costs, coverage rules, and broader healthcare priorities. A complete review may show that the existing plan still fits or that another available option deserves consideration.
Review Your 2027 Prescription Coverage Before Making a Change
Reviewing Part D coverage for 2027 comes down to a few practical questions: Are the medications you take still covered? Has the way the plan covers those prescriptions changed? Do the pharmacy arrangements and coverage rules still work for you?
Answering those questions before making a plan decision creates a much clearer picture than comparing plans based on a single premium, tier, or benefit. For some beneficiaries, the review may identify a reason to explore another available option. For others, it may confirm that their current drug coverage continues to fit.
Speak with a licensed ProCare Consulting advisor to review how your current medications are covered for 2027 and discuss available Medicare drug coverage options when appropriate.
